Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate. - Satake N; Duong C; Yoshida S; Oestergaard M; Chen C; Peralta R; Guo S; Seth PP; Li Y; Beckett L; Chung J; Nolta J; et al. (Molecular medicine (Cambridge, Mass.), 2016)